“… More recently, I engaged Belas Consulting, Inc., to evaluate my Bioanalytical business offerings, identify strengths & weaknesses, and provide a gap analysis on next steps to enhance this service offering and drive incremental levels of new business.  In summary, my experience was exceptional, as Frank delivered on all expectations in a professional, timely, and cost-effective manner. I attribute this outcome to Frank’s deep-seated bioanalytical expertise, sourcing & business know-how, and practical approaches to addressing problems within these areas.  Frank’s proven ability to develop Bioanalytical organizations from a start-up mode and/or be a catalyst for disruptive change for pre-existing organizations with challenging issues, told me that Belas Consulting, Inc. was a great fit for me. I give him my unqualified recommendation as a bioanalytical and outsourcing consultant, as his services will be an asset to any organization that requires such expertise and desires a pragmatic, real-world approach toward achieving their goals.”

Anonymous
Vice-President,  Drug Development
Not-For-Profit U.S.-based CRO

“It is with great pleasure that I endorse and highly recommend Dr. Frank Belas.  I have worked closely with Frank for over 20 years during my role as both the President of Advion BioServices and more recently as a Vice President within Quintiles/IQVIA/Q2 Solutions.  Frank is an experienced results-oriented senior manager who has an exceptional track record of getting things done and executing change management.  I consider Frank to be one of the best results-oriented managers I have worked with in my career spanning over 30 years.”

Thomas Kurz
Vice-President, Strategic Partnerships
Q2 Solutions BioSciences LLC
Co-Founder of Advion BioSciences, Inc.

“… Frank is in the top tier of experts that I have worked with in my nearly thirty years of pharmaceutical research.”

Andrew M. Dahlem, Ph.D.
Vice-President and COO (retired)
Eli Lilly and Company

“Dr. Frank Belas’ ability to quickly define and communicate project scope, anticipate challenges, set clear expectations and secure buy-in from all parties has been a trademark of his work that I have appreciated time and time again. Dr. Belas is truly capable of de-risking a project through establishing clarity on all project aspects in a very professional manner. Anyone in the drug development business whether an innovator or contract research organization knows this is the absolute difference between delivering the project as planned or settling for mediocrity.”

John Bucksath
CEO, KCAS Bioanalytical & Biomarker Services

“I have known Dr. Belas to possess the highest levels of honor and integrity and I have seen this repeatedly expressed in both the work he produces and the way he produces the work. Frank has a proven track record of high quality and reliable delivery and I would recommend him without reservation to provide timely data and solutions in his area of scientific expertise.”

Andrew M. Dahlem, Ph.D.
Vice-President and COO (retired)
Eli Lilly and Company

“I have worked with Dr. Frank Belas as a researcher and drug developer for nearly 25 years.  Frank approaches his work with the highest integrity and commitment.  He has a natural and proven gift to understand scientific and operational details which prove critical to a project’s quality and success… Dr. Belas’ deep understanding of bioanalytical sciences, extensive experience in method development, validation and analyses, and commitment to excellence positions him as an ideal resource for both small and large pharmaceutical companies as well as bioanalytical organizations to ensure fit for purpose bioanalytical capabilities that meet global regulatory requirements.”

Anonymous
Vice-President, Global Regulatory Affairs
Top 10 Pharmaceutical Company